Instil Bio, Inc. Cash and Restricted Cash
Instil Bio, Inc. (TIL) had Cash and Restricted Cash of $5.79 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-13
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.79M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.14M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6.80M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6.08M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $5.79M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $5.14M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $6.80M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $6.08M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $7.84M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $16.33M 10-Q · filed 2026-05-15 |
| 2024-12-31 | $10.63M 10-Q · filed 2026-08-13 |
| 2024-09-30 | $6.66M 10-Q · filed 2025-11-13 |
| 2024-06-30 | $6.78M 10-Q · filed 2025-08-13 |
| 2024-03-31 | $5.48M 10-Q · filed 2025-05-13 |
| 2023-12-31 | $10.70M 10-K · filed 2026-03-27 |
| 2023-09-30 | $10.15M 10-Q · filed 2024-11-13 |
| 2023-06-30 | $22.93M 10-Q · filed 2024-08-13 |
| 2023-03-31 | $28.02M 10-Q · filed 2024-05-10 |
| 2022-12-31 | $43.72M 10-K · filed 2025-03-04 |
| 2022-09-30 | $41.62M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $42.96M 10-Q · filed 2023-08-14 |
| 2022-03-31 | $61.97M 10-Q · filed 2023-05-11 |
| 2021-12-31 | $38.09M 10-K · filed 2024-03-21 |
| 2021-09-30 | $20.90M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $566.77M 10-Q · filed 2022-08-12 |
| 2021-03-31 | $609.69M 10-Q · filed 2022-05-16 |
| 2020-12-31 | $241.76M 10-K · filed 2023-03-31 |
| 2020-09-30 | $170.68M 10-Q · filed 2021-11-15 |
| 2020-06-30 | $181.84M 10-Q · filed 2021-08-12 |
| 2020-03-31 | $5.61M 10-Q · filed 2021-05-13 |
| 2019-12-31 | $8.89M 10-K · filed 2022-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |